|
Jun 27
|
Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations
|
|
Jun 26
|
Moderna (MRNA) Outperforms Broader Market: What You Need to Know
|
|
Jun 26
|
The Top 5 Analyst Questions From Moderna’s Q1 Earnings Call
|
|
Jun 25
|
Seeking a Cure for Sickly Corporate Governance at SinoVac
|
|
Jun 25
|
Moderna (MRNA): Buy, Sell, or Hold Post Q1 Earnings?
|
|
Jun 24
|
Moderna, Inc. (MRNA): A Bull Case Theory
|
|
Jun 24
|
Moderna RSV Vaccine Gains Expanded FDA Approval for Younger Adults
|
|
May 16
|
S&P 500 Gains & Losses Today: Index Notches 5-Day Win Streak Despite Consumer Sentiment Slide
|
|
May 16
|
Was Jim Cramer Right About Moderna (MRNA) Stock?
|
|
May 16
|
Moderna (NasdaqGS:MRNA) Begins Phase 1 Study on Novel Cancer Therapy Candidate
|
|
May 16
|
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
|
|
May 14
|
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue Shortfall
|
|
May 14
|
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
|
|
May 14
|
Moderna, Inc. (MRNA): Among the Best Growth Stocks to Buy and Hold for the Long Term
|
|
May 12
|
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know
|
|
May 12
|
Trump expected to sign order to slash US drug prices
|
|
May 12
|
Why Moderna Merged Its Tech and HR Departments
|
|
Apr 17
|
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
|
|
Apr 17
|
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|
|
Apr 17
|
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
|